Reversion of Hormone Treatment Resistance with the Addition of an mTOR Inhibitor in Endometrial Stromal Sarcoma

por Martin-Liberal, J., Benson, C., Messiou, C., Fisher, C., Judson, I.
Publicado 2014

Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma

por Diem, S, Kasenda, B, Spain, L, Martin-Liberal, J, Marconcini, R, Gore, M, Larkin, J
Publicado 2016

Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours

por Martin-Liberal, J, Gil-Martín, M, Sáinz-Jaspeado, M, Gonzalo, N, Rigo, R, Colom, H, Muñoz, C, Tirado, O M, García del Muro, X
Publicado 2014